Mer­ck seeks more ap­provals for in­fec­tious dis­ease drug

3 years ago
R&D
FDA+

Third Rock-backed au­toim­mune biotech turns off the lights

3 years ago
People
R&D

Kite CEO Christi Shaw to de­part Gilead CAR-T unit

3 years ago
People

Mod­er­na boasts 'step for­ward' with PhI­II da­ta on flu vac­cine, but an­a­lysts are not so sure

3 years ago
R&D

FDA gives the OK to Chiesi for treat­ment of ul­tra-rare en­zyme de­fi­cien­cy dis­ease

3 years ago
Pharma
FDA+

Up­dat­ed: Pfiz­er drops half of par­tic­i­pants from Ly­me tri­al af­ter say­ing re­search con­trac­tor broke rules

3 years ago
R&D
Pharma

Au revoir, Sanofi: John Reed dash­es to J&J; Zen­tal­is plucks new COO from GSK

3 years ago
Peer Review

Bio­gen chair­man Pa­padopou­los, who saw com­pa­ny through highs and lows, to re­tire

3 years ago
People
Pharma

UK could al­low rec­i­p­ro­cal drug ap­provals with US FDA as soon as 2024

3 years ago
Pharma
FDA+

Bris­tol My­ers, Pfiz­er team up with bas­ket­ball leg­end Ka­reem Ab­dul-Jab­bar on stroke risk cam­paign

3 years ago
Pharma
Marketing

Sen­ate be­gins quest to de­mys­ti­fy PBM­s' prac­tices as it mulls leg­is­la­tion

3 years ago
Pharma

Putting a twist on tar­get­ed ther­a­py, Vor Bio­phar­ma her­alds proof of con­cept for its gene-edit­ed stem cells

3 years ago
R&D
Cell/Gene Tx

Klick Health adds com­mer­cial ven­ture group for ear­ly-stage biotechs and ‘mod­ern’ health com­pa­nies

3 years ago
Pharma
Marketing

Rise in con­sumer con­ve­nience dis­rupts tra­di­tion­al phar­ma-to-physi­cian mar­ket­ing, ZS re­search finds

3 years ago
Pharma
Marketing

Man­u­fac­tur­ing roundup: Life sci­ences de­vel­op­ment planned for Texas; Eli Lil­ly to sup­ply in­sulin in­gre­di­ent to ...

3 years ago
Manufacturing

Ap­plied Ther­a­peu­tics show­cas­es ear­ly da­ta in PhI­II rare sug­ar dis­ease tri­al

3 years ago
R&D

Pfiz­er gives in­ter­im up­date on PARP in­hibitor com­bo treat­ment, earns pri­or­i­ty re­view at FDA

3 years ago
R&D

Flag­ship com­pa­ny teams up with Charles Riv­er for AI drug dis­cov­ery

3 years ago
R&D
Outsourcing

CAR-T biotech re­duces staff as it hunts for cap­i­tal to en­ter clin­ic next year

3 years ago
People
Startups

Ta­laris dis­con­tin­ues two tri­als, cuts staff and starts ‘strate­gic al­ter­na­tives’ search

3 years ago
People
R&D

Mer­ck hands Swedish biotech €10M cash to de­vel­op an­ti-in­flam­ma­to­ry drugs

3 years ago
Deals
R&D

Ex­clu­sive: Sanofi, Astel­las ven­ture arms add cash to Avi­lar's 'AT­AC' mis­sion

3 years ago
Financing
Startups

Biotech con­sol­i­da­tion con­tin­ues as Nas­daq-list­ed Ery­tech merges with phage ther­a­py de­vel­op­er

3 years ago
Deals

'Rare out­lier­s': Feng Zhang eyes a new path to ge­net­ic med­i­cine de­liv­ery with ex-Al­ny­lam lead­ers and $193M

3 years ago
Financing
Startups
First page Previous page 374375376377378379380 Next page Last page
A service from the Financial Times